Back to results
US 2021/0277355 A1Published application
Generating virus or other antigen-specific t cells from a naïve t cell population
AssigneeChildren's National Medical Center
InventorsCatherine BOLLARD, Conrad CRUZ, Patrick HANLEY
Life of this patent
Estimating the term…
Abstract
Safe, rapid and efficient methods for producing virus-specific or other antigen-specific T-cells from cord blood and other samples containing naive immune cells.
Claims10
1-51. (canceled)
A process for producing a plurality of tumor-associated antigen-specific T cells comprising:
- obtaining a sample comprising immune cells from a donor;
- separating said immune cells into T-cells and T-cell precursor cells and antigen presenting cells and antigen presenting precursors from said sample;
- reserving the separated T-cells and T-cell precursor cells;
- generating mature dendritic cells comprising contacting the separated antigen presenting cells and antigen presenting precursor cells with IL-4, GM-CSF, LPS and with at least one tumor-associated or tumor-specific antigen to produce a plurality of antigen-presenting dendritic cells that present the at least one tumor-associated or tumor-specific peptide antigen;
- contacting the reserved T-cells and T-cell precursor cells with the plurality of antigen-presenting dendritic cells in the presence of at least IL-7 and IL-15 to produce said plurality of tumor-associated antigen-specific T cells antigen specific T cells that recognize the ate least one peptide antigen;
- and
- recovering said plurality of tumor-associated antigen-specific T cells that recognize the at least one tumor associated or tumor specific peptide antigen.
4 more elements
Dependencies are inferred from the claim text.